BioSpace News Archive

Tris Pharma, Inc., a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder and related disorders, announced the launch of a new website for patients and their caregivers.

Industry veteran to lead corporate strategy and prepare for commercialization of Cytocom’s immune-modulating therapies developed with AIMS technology platform

ASTRO Studies Focused on (Ultra) Hypofractionated Treatments Were Shared, Highlighting Experience of >1,400 Patients

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez , the company’s president and chief executive officer, is scheduled to present a company overview at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020 at 12:00 p.m. Eastern Time . To access the live an

Former Biotech CEO and senior Merck executive James (Jay) Galeota joins Board of Directors

Continued to enroll and dose patients in Phase 1/2 clinical trial of BDTX-189, with Phase 1 portion on track to complete by first half of 2021 Strengthened Board of Directors with appointment of Robert A. Ingram as Chairman Bolstered executive team with appointment of Rachel Humphrey, M.D., as Chief Medical Officer Cash, cash equivalents, and investments of $333.1 million as of September 30, 2020, expected to be sufficient to fund operations into 2023

Arch Therapeutics, Inc., developer of novel self-assembling wound care and biosurgical devices, announces that it has raised approximately $1.1M from long-term shareholders.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in two investment conferences this month. Chief Executive Officer and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the 2020 Jefferies Virtual London Healthcare Conference being held on Novembe

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2020 Stifel Virtual Healthcare Conference on Wednesday, November 18, 2020. Inspire is scheduled to present at 11:20 a.m. Eastern Time. The presentation will be acce

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will participate in a fireside chat at the Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020, at 8:40 am Eastern Time, and conduct one-on-one investor meetings around the event. Details are as follows: Conference: Stifel 2020